Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 2/20 | 0.54 |
| ▸ | CA2 | P00918 | 2/20 | 0.54 |
| ▸ | CA9 | Q16790 | 2/20 | 0.54 |
| ▸ | LPL | P06858 | 12/20 | 0.50 |
| ▸ | LIPG | Q9Y5X9 | 12/20 | 0.50 |
| ▸ | CA12 | O43570 | 1/20 | 0.42 |
| ▸ | CA3 | P07451 | 1/20 | 0.42 |
| ▸ | CA4 | P22748 | 1/20 | 0.42 |
| ▸ | CA6 | P23280 | 1/20 | 0.42 |
| ▸ | CA5A | P35218 | 1/20 | 0.42 |
| ▸ | CA7 | P43166 | 1/20 | 0.42 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.42 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.42 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.42 |
| ▸ | AAK1 | Q2M2I8 | 1/20 | 0.41 |
| ▸ | F11 | P03951 | 1/20 | 0.41 |
| ▸ | SNCA | P37840 | 1/20 | 0.41 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.38 |
| ▸ | P4HB | P07237 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5850578 | 0.89 | CA1 (0.54) | CA1CA2CA9LPLLIPG | |
| SCHEMBL20763386 | 0.86 | CA1 (0.51) | CA1CA2CA9LPLLIPG | |
| SCHEMBL18346464 | 0.85 | CA1 (0.59) | CA1CA2CA9LPLLIPG | |
| SCHEMBL251345 | 0.84 | CA1 (0.53) | CA1CA2CA9LPLLIPG | |
| SCHEMBL24467420 | 0.83 | LPL (0.54) | CA1CA2CA9LPLLIPG | |
| SCHEMBL28334985 | 0.83 | LPL (0.54) | CA1CA2CA9LPLLIPG | |
| SCHEMBL16177371 | 0.82 | CA1 (0.48) | CA1CA2CA9LPLLIPG | |
| SCHEMBL15615744 | 0.82 | LPL (0.49) | CA1CA2CA9LPLLIPG | |
| SCHEMBL12077661 | 0.82 | CA1 (0.48) | CA1CA2CA9LPLLIPG | |
| SCHEMBL28981863 | 0.81 | CA1 (0.50) | CA1CA2CA9LPLLIPG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8962779-B2 | Method of forming polyaryl polymers | DOW GLOBAL TECHNOLOGIES LLC (US) | 2015-02-24 | — | — | US | disclosed |
| US-8962779-B2 | Method of forming polyaryl polymers | DOW GLOBAL TECHNOLOGIES LLC (US) | 2015-02-24 | — | — | US | disclosed |
| US-20150031847-A1 | METHOD OF FORMING POLYARYL POLYMERS | DOW GLOBAL TECHNOLOGIES LLC | 2015-01-29 | — | — | US | disclosed |
| US-20150031847-A1 | METHOD OF FORMING POLYARYL POLYMERS | DOW GLOBAL TECHNOLOGIES LLC | 2015-01-29 | — | — | US | disclosed |
| US-20150025262-A1 | BIS(ARYL)ACETAL COMPOUNDS | U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS NOTES COLLATERAL AGENT | 2015-01-22 | — | — | US | disclosed |
| US-20150025262-A1 | BIS(ARYL)ACETAL COMPOUNDS | U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS NOTES COLLATERAL AGENT | 2015-01-22 | — | — | US | disclosed |
| US-20150025262-A1 | BIS(ARYL)ACETAL COMPOUNDS | U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS NOTES COLLATERAL AGENT | 2015-01-22 | — | — | US | disclosed |
| US-8933239-B1 | Bis(aryl)acetal compounds | DOW GLOBAL TECHNOLOGIES LLC (US) | 2015-01-13 | — | — | US | disclosed |
| US-8933239-B1 | Bis(aryl)acetal compounds | DOW GLOBAL TECHNOLOGIES LLC (US) | 2015-01-13 | — | — | US | disclosed |
| US-8933239-B1 | Bis(aryl)acetal compounds | DOW GLOBAL TECHNOLOGIES LLC (US) | 2015-01-13 | — | — | US | disclosed |
| US-20120065353-A1 | CARBAZOLE POLYMER AND METHOD OF MANUFACTURING SAME | RICOH COMPANY, LTD., (JP) | 2012-03-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150025262-A1 | BIS(ARYL)ACETAL COMPOUNDS | BOLA2; BOLA2B, TARS1, CBR1 | CA1 1941/4885CA2 1097/4885CA9 753/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.